30 May, 2017
Therefore 63% are positive. As per Friday, October 23, the company rating was maintained by UBS. The firm earned "Neutral" rating on Thursday, September 8 by JP Morgan. The company was upgraded on Friday, October 14 by CapitalOne. As per Tuesday, February 23, the company rating was upgraded by Citigroup. The company was downgraded on Tuesday, December 1 by Barclays Capital. BMO Capital Markets maintained AbbVie Inc (NYSE:ABBV) rating on Friday, April 28. The stock now has a consensus rating of "Hold" and an average price target of $72.18. As per Wednesday, June 8, the company rating was downgraded by Morgan Stanley.
Selway Asset Management increased Abbvie (ABBV) stake by 33.25% reported in 2016Q4 SEC filing. Michael Robert A. sold $335,068 worth of stock. The Mrj Capital Inc holds 49,000 shares with $3.07 million value, down from 58,400 last quarter.
03/07/2017 - AbbVie Inc. had its " rating reiterated by analysts at Jefferies. Corporate insiders own 0.11% of the company's stock. The Thompson Investment Management Inc holds 77,232 shares with $4.84M value, up from 72,387 last quarter.
Analysts await AbbVie Inc (NYSE:ABBV) to report earnings on August, 4. It has underperformed by 6.07% the S&P500. In the last three months, insiders sold 292,134 shares of company stock valued at $19,087,407. It has outperformed by 12.98% the S&P500. The company reported $1.28 EPS for the quarter, beating the Zacks' consensus estimate of $1.26 by $0.02. Cam Grp Holdings A S stated it has 80,825 shares. Norges Bank acquired a new position in AbbVie during the fourth quarter worth approximately $823,984,000. Thompson Rubinstein Inv Management Incorporated Or holds 1.99% or 85,932 shares in its portfolio. 31,120 are owned by State Of Alaska Department Of Revenue. Moreover, Iberiabank has 1.94% invested in AbbVie Inc (NYSE:ABBV). Lathrop Investment Mngmt Corporation owns 0.12% invested in AbbVie Inc (NYSE:ABBV) for 6,394 shares. Pegasus Partners Ltd. increased its stake in shares of AbbVie by 15.0% in the third quarter. New Jersey-based Beacon Tru has invested 1.42% in AbbVie Inc (NYSE:ABBV). RICHMOND TIMOTHY J. also sold $1.47M worth of AbbVie Inc (NYSE:ABBV) shares. American National Bank raised its stake in shares of AbbVie by 13.8% in the first quarter. Bollard Ltd Liability accumulated 0.02% or 11,088 shares. Delta Asset Mgmt Lc Tn reported 3,525 shares. First Foundation Advisors reported 0.07% of its portfolio in AbbVie Inc (NYSE:ABBV). Sigma Planning Corp reported 0.33% stake.
Since December 2, 2016, it had 0 insider buys, and 9 selling transactions for $19.62 million activity.
Baker Bros Advisors Lp, which manages about $8.20B and $10.20B US Long portfolio, upped its stake in Amarin Corporation Plc (NASDAQ:AMRN) by 1.54 million shares to 22.17 million shares, valued at $68.28M in 2016Q4, according to the filing. The company has market cap of $152.11 million. The Firm is focused on the acquisition, ownership, and operation of single-tenant, industrial properties across the United States. The Firm is engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products.
Investors sentiment decreased to 0.98 in Q4 2016.
The stock decreased 0.81% or $1.56 on May 26, reaching $190.39.
Vetr upgraded shares of AbbVie Inc (NYSE:ABBV) from a buy rating to a strong-buy rating in a research note published on Monday, May 8th.
A number of other hedge funds have also recently added to or reduced their stakes in ABBV. Harvest Capital Mgmt owns 0.1% invested in AbbVie Inc (NYSE:ABBV) for 3,809 shares. Hengehold Capital Mgmt Lc owns 11,000 shares or 0.01% of their USA portfolio. HURWICH THOMAS A. sold $143,031 worth of AbbVie Inc (NYSE:ABBV) on Tuesday, February 28.
Among 18 analysts covering Abbvie Inc (NYSE:ABBV), 7 have Buy rating, 1 Sell and 10 Hold. Brown Brothers Harriman accumulated 65,743 shares.
AbbVie Inc (NYSE:ABBV) traded down 0.39% during trading on Monday, hitting $66.06. Dillon And Associates Inc reported 125,651 shares. Synovus Corp has invested 0.2% in AbbVie Inc (NYSE:ABBV). Wealthtrust has 191 shares for 0.01% of their portfolio. Court Place Limited invested in 20,269 shares.
Among 18 analysts covering Abbvie Inc (NYSE:ABBV), 7 have Buy rating, 1 Sell and 10 Hold. Therefore 72% are positive. As per Tuesday, July 28, the company rating was downgraded by Credit Agricole. On Thursday, May 25 the stock rating was maintained by Jefferies with "Buy". As per Friday, December 18, the company rating was initiated by Atlantic Securities. BMO Capital Markets reissued a "market perform" rating and set a $66.00 price objective on shares of AbbVie in a report on Wednesday, May 17th. On Wednesday, April 6 the stock rating was initiated by Societe Generale with "Sell". The stock of AbbVie Inc (NYSE:ABBV) has "Outperform" rating given on Friday, September 2 by Raymond James. The company has market cap of $104.73 billion.
Receive AbbVie Inc. News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AbbVie Inc. with MarketBeat.com's FREE daily email newsletter.